Recurrent Inactivation of the PRDM1 Gene in Primary Central Nervous System Lymphoma

Primary lymphomas of the CNS (PCNSLs) show molecular features of the late germinal center exit B-cell phenotype and are impaired in their terminal differentiation as indicated by a lack of immunoglobulin class switching. Because the positive regulatory domain I protein with ZNF domain (PRDM1/BLIMP1) is a master regulator of terminal B-cell differentiation into plasma cells, we investigated a series of 21 PCNSLs for the presence of mutations in the PRDM1 gene and alterations in the expression pattern of the PRDM1 protein. Direct sequencing of all coding exons of the PRDM1 gene identified deleterious mutations associated with abrogation of PRDM1 protein expression in 4 of 21 (19%) PCNSLs. Thus, similar to systemic diffuse large B-cell lymphomas, PRDM1 may be a tumor suppressor in some PCNSL and contribute to lymphomagenesis by impairing terminal differentiation.

[1]  T. Maniatis,et al.  Identification and characterization of a novel repressor of beta-interferon gene expression. , 1991, Genes & development.

[2]  Mark M. Davis,et al.  Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells , 1994, Cell.

[3]  B. Mock,et al.  The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10. , 1996, Genomics.

[4]  G. Reifenberger,et al.  Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. , 1999, The American journal of pathology.

[5]  G. Cattoretti,et al.  Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo1 , 2000, The Journal of Immunology.

[6]  M. Deckert,et al.  Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment , 2000, Journal of the Neurological Sciences.

[7]  K. Wright,et al.  Positive Regulatory Domain I Binding Factor 1 Silences Class II Transactivator Expression in Multiple Myeloma Cells* , 2001, The Journal of Biological Chemistry.

[8]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[9]  Liming Yang,et al.  Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. , 2002, Immunity.

[10]  R. Siebert,et al.  Interphase Cytogenetic Analysis of Lymphoma‐Associated Chromosomal Breakpoints in Primary Diffuse Large B‐Cell Lymphomas of the Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[11]  K. Wright,et al.  Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines1 , 2003, The Journal of Immunology.

[12]  C. Schaller,et al.  Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. , 2004, Blood.

[13]  G. Reifenberger,et al.  Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. , 2005, The American journal of pathology.

[14]  Giorgio Cattoretti,et al.  PRDM1/Blimp‐1 is expressed in human B‐lymphocytes committed to the plasma cell lineage , 2005, The Journal of pathology.

[15]  K. Calame,et al.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.

[16]  W. Chan,et al.  Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. , 2006, Blood.

[17]  Stefano Monti,et al.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma , 2006, The Journal of experimental medicine.

[18]  W. Klapper,et al.  Chromosomal Translocations Fusing the BCL6 Gene to Different Partner Loci Are Recurrent in Primary Central Nervous System Lymphoma and May Be Associated With Aberrant Somatic Hypermutation or Defective Class Switch Recombination , 2006, Journal of neuropathology and experimental neurology.

[19]  Juan F. García,et al.  Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. , 2003, Haematologica.

[20]  G. Reifenberger,et al.  Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma , 2007, Acta Neuropathologica.

[21]  S. Nutt,et al.  Terminal differentiation of lymphocytes depends on Blimp-1. , 2007, Current opinion in immunology.

[22]  G. Tate,et al.  Novel BLIMP1/PRDM1 gene mutations in B-cell lymphoma. , 2007, Cancer genetics and cytogenetics.

[23]  R. Spang,et al.  Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell , 2008, Leukemia.